CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 254 filers reported holding CATALYST PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.94 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,208 | -99.9% | 360 | -99.9% | 0.00% | -100.0% |
| Q2 2023 | $3,431,501 | -38.4% | 255,320 | -24.0% | 0.32% | -34.0% |
| Q1 2023 | $5,569,222 | -16.8% | 335,900 | -6.6% | 0.48% | -15.7% |
| Q4 2022 | $6,692,280 | +8.3% | 359,800 | -25.3% | 0.57% | +1.3% |
| Q3 2022 | $6,180,000 | +34.5% | 481,700 | -26.5% | 0.56% | +51.9% |
| Q2 2022 | $4,595,000 | -14.7% | 655,600 | +0.9% | 0.37% | +5.7% |
| Q1 2022 | $5,388,000 | +8063.6% | 649,900 | +3722.9% | 0.35% | +3063.6% |
| Q4 2017 | $66,000 | – | 17,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANAKA CAPITAL MANAGEMENT INC | 208,189 | $1,726,000 | 3.48% |
| FRIESS ASSOCIATES LLC | 571,940 | $4,741,000 | 2.53% |
| GABLES CAPITAL MANAGEMENT INC. | 438,764 | $3,637,000 | 2.28% |
| Prairiewood Capital, LLC | 258,073 | $2,139,000 | 1.50% |
| Quantedge Capital Pte Ltd | 597,300 | $4,952,000 | 1.46% |
| ARMISTICE CAPITAL, LLC | 8,372,000 | $69,404,000 | 1.34% |
| SummerHaven Investment Management, LLC | 158,473 | $1,314,000 | 0.74% |
| Capital Impact Advisors, LLC | 99,322 | $823,000 | 0.60% |
| EAM Investors, LLC | 365,415 | $3,029,000 | 0.56% |
| GLOBEFLEX CAPITAL L P | 304,515 | $2,524,000 | 0.51% |